Examinando por Autor "Gil-de-Miguel, Angel"

Mostrando 1 - 4 de 4

Differences in Trends in Admissions and Outcomes among Patients from a Secondary Hospital in Madrid during the COVID-19 Pandemic: A Hospital-Based Epidemiological Analysis (2020–2022)
(MDPI, 2023-07-24) Garcia-Carretero, Rafael; Vazquez-Gomez, Oscar; Ordoñez-Garcia, Maria; Garrido-Peño, Noelia; Gil-Prieto, Ruth; Gil-de-Miguel, Angel
Hospitalization burden and epidemiology of the COVID-19 pandemic in Spain (2020-2021)
(Springer Science and Business Media LLC, 2023-07-18) Garcia-Carretero, Rafael; Vazquez-Gomez, Oscar; Gil-Prieto, Ruth; Gil-de-Miguel, Angel
Background Spain had some of Europe’s highest incidence and mortality rates for coronavirus disease 2019 (COVID19). Here we describe the epidemiology and trends in hospitalizations, the number of critical patients, and deaths in Spain in 2020 and 2021. Methods We performed a descriptive, retrospective, nationwide study using an administrative database, the Minimum Basic Data Set at Hospitalization, which includes 95–97% of discharge reports for patients hospitalized in Spain in 2020 and 2021. We analyzed the number of hospitalizations, admissions to intensive care units, and deaths and their geographic distribution across regions of Spain. Results As of December 31, 2021, a total of 498,789 patients (1.04% of the entire Spanish population) had needed hospitalization. At least six waves of illness were identified. Men were more prone to hospitalization than women. The median age was 66. A total of 54,340 patients (10.9% of all hospitalizations) had been admitted to the intensive care unit. We identified 71,437 deaths (mortality rate of 14.3% among hospitalized patients). We also observed important differences among regions, with Madrid being the epicenter of hospitalizations and mortality. Conclusions We analyzed Spain’s response to COVID-19 and describe here its experiences during the pandemic in terms of hospitalizations, critical illness, and deaths. This research highlights changes over several months and waves and the importance of factors such as vaccination, the predominant variant of the virus, and public health interventions in the rise and fall of the outbreaks.
Hospitalization Burden Related to Herpes Zoster Infection in Spain (2016–2019)
(Springer Science and Business Media LLC, 2022-11-08) Corcuera-Munguia, Marta; Gil-Prieto, Ruth; Garcia-Carretero, Rafael; Gil-de-Miguel, Angel
Introduction: Herpes zoster (HZ) and its complications still represent a significant burden for patients and health care systems. In Spain, vaccination is progressively being introduced and recommended for patients between 65 and 80 years old and patients [ 18 years of age suffering from certain immunosuppression conditions. The aim of this study is to estimate the number of hospital admissions related to HZ from 2016 to 2019 in Spain. Methods: Data were collected from the Minimum Basic DataSet (MBDS) and codified according to the Spanish version of the 10th International Classification of Disease (ICD-10- CM codes B02—B02.9). Among others, variables such as sex, age and presence of complications were included. Results: A total of 27,642 hospitalizations were identified (90% in patients [ 50 and 45.8% in patients [80). Women represented 51.2% of the patients, and 59.9% of patients presented complications related to HZ. The hospitalization rate was 17.74, the mortality rate was 1.2, and the case fatality rate was 6.75%. All rates were significantly higher with age, among men and in complicated HZ. Immunosuppression status for which vaccination had been recommended represented 22.7% of the total cases, affecting mostly individuals [ 65 and causing more deaths in those[ 80 years. The estimated annual cost of hospitalization for herpes zoster was €35,738,285, and the mean cost per patient was €5172. Conclusion: The hospitalization burden for HZ is still important in Spain. Data on the current epidemiology are important to evaluate future vaccination strategies.
Insulin resistance is a cardiovascular risk factor in hypertensive adults without type 2 diabetes mellitus
(Springer Science and Business Media LLC, 2023-10-09) Garcia-Carretero, Rafael; Vazquez-Gomez, Oscar; Gil-Prieto, Ruth; Gil-de-Miguel, Angel